dc.contributor | Departament de Salut |
dc.contributor.author | Programa d'Harmonització Farmacoterapèutica |
dc.date.accessioned | 2020-11-06T08:01:32Z |
dc.date.available | 2020-11-06T08:01:32Z |
dc.date.issued | 2020-06-29 |
dc.identifier.citation | Programa d'Harmonització Farmacoterapèutica. Risankizumab per al tractament de la psoriasi en plaques en pacients adults. Barcelona: Servei Català de la Salut; 2020. |
dc.identifier.uri | https://hdl.handle.net/11351/5391 |
dc.description | Risankizumab; Biological medicine; Psoriasis; Adult patients |
dc.description.abstract | Psoriasis is an inflammatory, immunomediated and chronic skin disease that runs with
referrals and relapses. It is characterized by the hyperproliferation of keratinocytes and T lymphocytes in the skin that overexpress proinflammatory mediators, resulting in thick, scaly skin lesions. The prevalence of psoriasis in Europe ranges from 0.6% to 8.5%. In Spain, it is estimated to be 2.3%. The most common form is plaque psoriasis, which affects 80-90% of patients. Among patients with plaque psoriasis, 80% have mild or moderate disease and 20% severe disease. |
dc.language.iso | cat |
dc.publisher | Servei Català de la Salut |
dc.rights | Attribution-NonCommercial-NoDerivatives 4.0 International |
dc.rights.uri | http://creativecommons.org/licenses/by-nc-nd/4.0/ |
dc.source | Scientia |
dc.subject | Psoriasi - Tractament |
dc.subject | Medicaments - Assaigs clínics |
dc.subject | Avaluació de resultats (Assistència sanitària) |
dc.subject.mesh | Psoriasis |
dc.subject.mesh | /drug therapy |
dc.subject.mesh | Drug Evaluation |
dc.subject.mesh | Clinical Trials as Topic |
dc.title | Risankizumab per al tractament de la psoriasi en plaques en pacients adults |
dc.type | info:eu-repo/semantics/report |
dc.subject.decs | psoriasis |
dc.subject.decs | /farmacoterapia |
dc.subject.decs | evaluación de medicamentos |
dc.subject.decs | ensayos clínicos como asunto |
dc.type.version | info:eu-repo/semantics/publishedVersion |
dc.audience | Professionals |
dc.rights.accessrights | info:eu-repo/semantics/openAccess |